Use iliac bone graft + use bone morphogenetic protein + use bone derived allograft MSCs + Use adipose tissue derived MSCs + Use amnion/placental derived MSCs
Phase 2/3Completed 0 watching 0 views this week⚡ Active
57
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Disc Degenerative Disease
Conditions
Disc Degenerative Disease, Spine Fusion for Degenerative Spine Disease
Trial Timeline
Oct 13, 2015 → Jan 31, 2020
NCT ID
NCT07187362About Use iliac bone graft + use bone morphogenetic protein + use bone derived allograft MSCs + Use adipose tissue derived MSCs + Use amnion/placental derived MSCs
Use iliac bone graft + use bone morphogenetic protein + use bone derived allograft MSCs + Use adipose tissue derived MSCs + Use amnion/placental derived MSCs is a phase 2/3 stage product being developed by Brain Biotech for Disc Degenerative Disease. The current trial status is completed. This product is registered under clinical trial identifier NCT07187362. Target conditions include Disc Degenerative Disease, Spine Fusion for Degenerative Spine Disease.
Hype Score Breakdown
Clinical
22
Activity
15
Company
2
Novelty
7
Community
8
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT07187362 | Phase 2/3 | Completed |
Competing Products
20 competing products in Disc Degenerative Disease